Additional file 23: Table S13. The serum cytokines in 12 CADASIL patients (Case) and 10 healthy family members (Control)
Additional file 13: Table S3. The metagenomic sequencing data of 52 fecal samples
Additional file 9: Fig. S9. The significantly decreased virulence factors (VFs) in relative abundanc...
Additional file 4: Fig. S4. The top 4 significantly decreased microbial pathways in CADASIL patients...
Additional file 21: Table S11. The statistical result of serum neurotransmitters of CADASIL patients...
Additional file 22: Table S12. The content of serum glutamic acid and gamma-aminobutyric acid and th...
Additional file 24: Table S14. Differentiated abundant VFs in CADASIL patients compared to controls
Additional file 16: Table S6. The significantly different functional pathways in relative abundance ...
Additional file 17: Table S7. The significantly different content of fecal metabolites between CADAS...
Additional file 15: Table S5. The significantly different species in relative abundance between CADA...
Additional file 25: Table S15. Significantly decreased VFs in CADASIL patients compared to controls
Additional file 26: Table S16. The significant correlation between several differential VFs and infl...
Additional file 10: Fig. S10. The potential brain-gut-microbe axis in CADASIL with NOTCH3 mutation. ...
Additional file 19: Table S9. The statistical result of differential serum metabolites by untargeted...
Additional file 20: Table S10. KEGG enriched pathways for differential serum metabolites between pat...
Additional file 1: Fig. S1. Flow chart and enrolled participants in the current study
Additional file 13: Table S3. The metagenomic sequencing data of 52 fecal samples
Additional file 9: Fig. S9. The significantly decreased virulence factors (VFs) in relative abundanc...
Additional file 4: Fig. S4. The top 4 significantly decreased microbial pathways in CADASIL patients...
Additional file 21: Table S11. The statistical result of serum neurotransmitters of CADASIL patients...
Additional file 22: Table S12. The content of serum glutamic acid and gamma-aminobutyric acid and th...
Additional file 24: Table S14. Differentiated abundant VFs in CADASIL patients compared to controls
Additional file 16: Table S6. The significantly different functional pathways in relative abundance ...
Additional file 17: Table S7. The significantly different content of fecal metabolites between CADAS...
Additional file 15: Table S5. The significantly different species in relative abundance between CADA...
Additional file 25: Table S15. Significantly decreased VFs in CADASIL patients compared to controls
Additional file 26: Table S16. The significant correlation between several differential VFs and infl...
Additional file 10: Fig. S10. The potential brain-gut-microbe axis in CADASIL with NOTCH3 mutation. ...
Additional file 19: Table S9. The statistical result of differential serum metabolites by untargeted...
Additional file 20: Table S10. KEGG enriched pathways for differential serum metabolites between pat...
Additional file 1: Fig. S1. Flow chart and enrolled participants in the current study
Additional file 13: Table S3. The metagenomic sequencing data of 52 fecal samples
Additional file 9: Fig. S9. The significantly decreased virulence factors (VFs) in relative abundanc...
Additional file 4: Fig. S4. The top 4 significantly decreased microbial pathways in CADASIL patients...